Table 1 Outcome measures in the MONITOR-PsA cohort study

Informed consent

X

Demographics

X

Medical history

X

X

X

X

X

X

X

X

Medications

X

X

X

X

X

X

X

X

Physical examination

X

X

X

X

X

X

X

X

Routine blood tests (FBC, U&Es, LFTs, CRP and eGFR)

X

X

X

X

X

X

X

X

Immunology (RF, ACPA, ANA)

X

Radiographs of hands/feet/spine

X

X

X

X

Eligibility assessment

X

Adherence

X

X

X

X

X

X

X

68/66 Joint count

X

X

X

X

X

X

X

X

Leeds and SPARCC enthesitis index

X

X

X

X

X

X

X

X

Dactylitis count

X

X

X

X

X

X

X

X

Psoriasis assessment (PASI and BSA)

X

X

X

X

X

X

X

X

Physician VAS

X

X

X

X

X

X

X

X

Metrology with BASMI (if axial involvement)

X

X

X

X

Patient questionnaires (VAS, HAQ, SF36, PsAID, WPAI, BASDAI, BASFI)

X

X

X

X

X

X

X

X

TSQM questionnaire

X

X

X

X

X

X

X

EQ-5D-5L questionnaire

X

X

X

X

X

X

Healthcare utilisation data

X

X

X

X

X

Adverse event assessments

X

X

X

X

X

X

X

X